Jeffrey S. Hackman

CIK: 0001926254

Transaction Breakdown

Open Market Buys (P)2 (10.5%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)5 (26.3%)

Derivative conversions

Awards (A)12 (63.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

FENC

FENNEC PHARMACEUTICALS INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (19 total)

FENC
FENNEC PHARMACEUTICALS INC.
Oct 31, 2026
Award(A)
Direct
1.2K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Oct 12, 2026
Award(A)
Direct
2.2K shares at avg. $5.53$12K
FENC
FENNEC PHARMACEUTICALS INC.
Sep 30, 2026
Award(A)
Direct
1.2K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Aug 31, 2026
Award(A)
Direct
1.2K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Jul 31, 2026
Award(A)
Direct
1.2K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Jun 30, 2026
Award(A)
Direct
1.2K shares-
FENC
FENNEC PHARMACEUTICALS INC.
May 31, 2026
Award(A)
Direct
1.2K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Apr 30, 2026
Exercise(M)
Direct
1.2K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Mar 31, 2026
Award(A)
Stock Options
Direct
200K shares at avg. $5.77-
FENC
FENNEC PHARMACEUTICALS INC.
Mar 31, 2026
Exercise(M)
Direct
16.7K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Mar 31, 2026
Exercise(M)
Direct
1.2K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Mar 28, 2026
Exercise(M)
Direct
13.9K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Feb 18, 2026
Exercise(M)
Direct
13.7K shares-
FENC
FENNEC PHARMACEUTICALS INC.
May 19, 2025
Purchase(P)
Direct
14K shares at avg. $6.99$98K
FENC
FENNEC PHARMACEUTICALS INC.
May 16, 2025
Purchase(P)
Direct
1K shares at avg. $6.75$7K
FENC
FENNEC PHARMACEUTICALS INC.
Mar 28, 2025
Award(A)
Restricted Share Unit
Direct
75K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Mar 28, 2025
Award(A)
Stock Options
Direct
50K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Mar 28, 2025
Award(A)
Restricted Share Unit
Direct
75K shares-
FENC
FENNEC PHARMACEUTICALS INC.
Mar 28, 2025
Award(A)
Stock Options
Direct
50K shares-

		Type	Shares	Price		Ownership
Oct 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	1,159	-	$0	Direct
Oct 12, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	2,224	$5.53	$12,299	Direct
Sep 30, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	1,159	-	$0	Direct
Aug 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	1,159	-	$0	Direct
Jul 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	1,159	-	$0	Direct
Jun 30, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	1,159	-	$0	Direct
May 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A)	1,159	-	$0	Direct
Apr 30, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	1,159	-	$0	Direct
Mar 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Award(A) Stock Options	200,000	$5.77	-	Direct
Mar 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	16,695	-	$0	Direct
Mar 31, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	1,159	-	$0	Direct
Mar 28, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	13,943	-	$0	Direct
Feb 18, 2026	FENC FENNEC PHARMACEUTICALS INC.	Exercise(M)	13,710	-	$0	Direct
May 19, 2025	FENC FENNEC PHARMACEUTICALS INC.	Purchase(P)	13,965	$6.99	$97,615	Direct
May 16, 2025	FENC FENNEC PHARMACEUTICALS INC.	Purchase(P)	1,035	$6.75	$6,986	Direct
Mar 28, 2025	FENC FENNEC PHARMACEUTICALS INC.	Award(A) Restricted Share Unit	75,000	-	-	Direct
Mar 28, 2025	FENC FENNEC PHARMACEUTICALS INC.	Award(A) Stock Options	50,000	-	-	Direct
Mar 28, 2025	FENC FENNEC PHARMACEUTICALS INC.	Award(A) Restricted Share Unit	75,000	-	-	Direct
Mar 28, 2025	FENC FENNEC PHARMACEUTICALS INC.	Award(A) Stock Options	50,000	-	-	Direct

1-19 of 19 transactions

About Hackman Jeffrey S.

Hackman Jeffrey S. (SEC CIK 0001926254) files insider reports with the SEC as Chief Executive Officer of FENNEC PHARMACEUTICALS INC. (FENC).

Signal8 holds 13 ownership filings by Hackman Jeffrey S., all Form 4s, filed between Apr 3, 2025 and Nov 2, 2026. Those filings report 19 transactions, from Mar 28, 2025 to Oct 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hackman Jeffrey S.'s filings is in RESEARCH TRIANGLE PARK, NC.

Recent filings by Hackman Jeffrey S.

Oct 31, 2026: Grant or award of FENC shares (Form 4, code A).
Oct 12, 2026: Grant or award of FENC shares (Form 4, code A).
Sep 30, 2026: Grant or award of FENC shares (Form 4, code A).
Aug 31, 2026: Grant or award of FENC shares (Form 4, code A).
Jul 31, 2026: Grant or award of FENC shares (Form 4, code A).

Other insiders filing for FENNEC PHARMACEUTICALS INC. (FENC)

Evans Terry L, Chief Commercial Officer
Sayad Pierre Sargis, Chief Medical Officer
Cioffi Christiana Marie, Chief Strategy Officer
Andrade Robert, CHIEF FINANCIAL OFFICER
Brughera Marco Maria, Director
Raykov Rosty, Officer

How to read Form 4 transaction codes